Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
Crossref DOI link: https://doi.org/10.1186/cc14409
Published Online: 2015-03-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walle, J Vande
Johnson, S
Harvey, E
Kincaid, J
Text and Data Mining valid from 2015-03-16
Version of Record valid from 2015-03-16
Article History
First Online: 16 March 2015
Free to read: This content has been made available to all.